Navigation Links
HDMA Statement On House Passage Of Federal Traceability Legislation
Date:6/3/2013

ARLINGTON, Va., June 3, 2013 /PRNewswire-USNewswire/ -- HDMA President and CEO John M. Gray released the following statement on the voice-vote passage of the Safeguarding America's Pharmaceuticals Act of 2013 (H.R. 1919) by the House of Representatives:

"After nearly a decade of working to create a federal traceability standard for pharmaceuticals, HDMA is pleased by the House of Representatives vote today to pass the Safeguarding America's Pharmaceuticals Act of 2013. Eliminating the cumbersome patchwork of state requirements is a bipartisan solution that will offer the clarity the industry needs to ensure medicines are continued to be delivered safely and on time to the patients who need them. HDMA thanks Reps. Bob Latta (R-Ohio), Jim Matheson (D-Utah) for their leadership on this important issue and are hopeful that they will join with their colleagues in the Senate to send federal traceability legislation to President Obama this summer."   

About HDMA
HDMA is the national association representing primary healthcare distributors, the vital link between the nation's pharmaceutical manufacturers and healthcare providers. Each business day, HDMA member companies ensure that nine million prescription medicines and healthcare products are delivered safely and efficiently to more than 200,000 pharmacies, hospitals, long-term care facilities, clinics and others nationwide. HDMA and its members work daily to provide value and achieve cost savings, an estimated $42 billion each year to our nation's healthcare system. For more information, visit www.HealthcareDistribution.org.


'/>"/>
SOURCE Healthcare Distribution Management Association
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Statement: Bayer Mourns Passing of Senator Frank Lautenberg
2. CHPA Statement on Alabama Drug Abuse Task Force Report
3. Lilly Statement on Indiana Biosciences Research Institute
4. American Academy of Ophthalmology Issues Statement on Provisions to Pharmaceutical Compounding Quality and Accountability Act
5. PTC Therapeutics, Inc. Files Registration Statement for Proposed Initial Public Offering
6. Statement By Dinesh Thakur Regarding US Governments Case Against Ranbaxy
7. Epizyme, Inc. Files Registration Statement for Proposed Initial Public Offering
8. Statement from the Cystic Fibrosis Foundation on Promising Phase 2 Clinical Trial Results of Kalydeco and VX-661 (Vertex Pharmaceuticals Inc.)
9. Medical Alarm Concepts Files Information Statement and Provides Update on Corporate Activity
10. Joint Statement On The Presidents Budget From The American Society Of Clinical Oncology, Community Oncology Alliance, ION Solutions and The US Oncology Network
11. Receptos Files Registration Statement for Proposed Initial Public Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... CINCINNATI , Feb. 17, 2017  Ethicon, ... Torax Medical, Inc., a privately held medical device ... Reflux Management System, a novel minimally invasive ... acquisition of Torax Medical will enable Ethicon to ... the anatomy-altering laparoscopic Nissen fundoplication surgical procedure. 1 ...
(Date:2/17/2017)... and Markets has announced the addition of the "Pharmaceutical Contract Manufacturing ... ... the US, Canada , Japan , ... of World. Annual estimates and forecasts are provided for the period 2015 ... Market data and analytics are derived from primary and secondary research. ...
(Date:2/17/2017)... AMSTERDAM , Feb. 17, ... connected health offerings at the  ...  (NYSE: PHG,AEX: PHIA), a global ... a broad range of population ... personal health solutions, fully integrated in a ...
Breaking Medicine Technology:
(Date:2/19/2017)... ... February 19, 2017 , ... ... home healthcare, will join forces with Healthwise ® at HIMSS 2017 ... the industry leader in evidence-based health education, technology and services, will demonstrate a ...
(Date:2/18/2017)... ... , ... Park Cities Pet Sitter President, Joette White, has been featured on ... The episode, which was posted this week, features a 30-minute interview of White ... Cities Pet Sitter’s being awarded the 2017 National Association of Professional Pet Sitter’s Business ...
(Date:2/17/2017)... ... February 17, 2017 , ... ... and sustainable systems change designed to further positively impact the health and wellness ... Trustees has long considered it our duty to seriously consider releasing our assets ...
(Date:2/17/2017)... ... February 17, 2017 , ... ... Prevent a Warning Letter, **An FDAnews Webinar**, Feb. 23, 2017 — 1:30 p.m. ... distinguish between corrective action (CA) and preventive action (PA)? , The methods share ...
(Date:2/17/2017)... , ... February 17, 2017 , ... ... operations executives and focusing on all facets of clinical trial planning and management. ... , patient engagement, and more. In addition, attendees stopping by Pharmica’s booth were ...
Breaking Medicine News(10 mins):